Truist Financial Corp Exact Sciences Corp Transaction History

Truist Financial Corp

$62.9 Billion
Q3 2024

A detailed history of Truist Financial Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Truist Financial Corp holds 13,922 shares of EXAS stock, worth $736,613. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,922

Previous 15,829 12.05%

Holding current value

$736,613

Previous $668,000 41.77%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $80,914 - $135,072	-1,907 Reduced 12.05%	13,922 $947,000
Q2 2024 Aug 20, 2024	SELL	$41.33 - $74.26 $78,196 - $140,499	-1,892 Reduced 10.68%	15,829 $668,000
Q1 2024 May 10, 2024	SELL	$56.27 - $73.77 $89,075 - $116,777	-1,583 Reduced 8.2%	17,721 $1.22 Million
Q4 2023 Feb 02, 2024	BUY	$59.06 - $75.72 $53,626 - $68,753	908 Added 4.94%	19,304 $1.43 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $56,774 - $85,273	-861 Reduced 4.47%	18,396 $1.25 Million
Q2 2023 Aug 01, 2023	BUY	$62.68 - $95.05 $44,502 - $67,485	710 Added 3.83%	19,257 $1.81 Million
Q1 2023 May 05, 2023	BUY	$47.19 - $70.77 $20,857 - $31,280	442 Added 2.44%	18,547 $1.26 Million
Q4 2022 Feb 17, 2023	SELL	$30.35 - $53.15 $10,804 - $18,921	-356 Reduced 1.93%	18,105 $896,000
Q3 2022 Oct 26, 2022	SELL	$31.97 - $49.37 $19,725 - $30,461	-617 Reduced 3.23%	18,461 $600,000
Q2 2022 Jul 22, 2022	SELL	$35.61 - $76.23 $50,316 - $107,712	-1,413 Reduced 6.9%	19,078 $751,000
Q1 2022 Apr 22, 2022	SELL	$57.56 - $82.54 $257,983 - $369,944	-4,482 Reduced 17.95%	20,491 $1.43 Million
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $287,027 - $398,592	-3,959 Reduced 13.68%	24,973 $1.94 Million
Q3 2021 Nov 05, 2021	BUY	$90.24 - $124.05 $163,605 - $224,902	1,813 Added 6.69%	28,932 $2.76 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $90,194 - $134,117	963 Added 3.68%	27,119 $3.37 Million
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $1.09 Million - $1.45 Million	9,327 Added 55.42%	26,156 $3.45 Million
Q4 2020 Nov 19, 2021	SELL	$99.61 - $142.12 $680,435 - $970,821	-6,831 Reduced 28.87%	16,829 $2.23 Million
Q4 2020 Feb 18, 2021	BUY	$99.61 - $142.12 $790,504 - $1.13 Million	7,936 Added 50.47%	23,660 $3.14 Million
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $809,484 - $1.13 Million	11,101 Added 240.13%	15,724 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $28,153 - $46,838	505 Added 12.26%	4,623 $402,000
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $281,559 - $775,884	-7,429 Reduced 64.34%	4,118 $239,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $896,740 - $1.15 Million	11,547 New	11,547 $1.07 Million

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Exact Sciences Corp Transaction History